Candidal epididymo-orchitis: Case report and review

Clinical Infectious Diseases

Volumn 26, Issue 4, 1998, Pages 942-945

  Jenkin, Grant A ^a,b   Choo, Marcus ^a   Hosking, Patrick ^a   Johnson, Paul D R ^a  

^a AUSTIN HEALTH   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ABSCESS DRAINAGE; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; CASE REPORT; CLINICAL EXAMINATION; EPIDIDYMITIS; HISTOPATHOLOGY; HUMAN; MALE; ORCHIECTOMY; ORCHITIS; PRIORITY JOURNAL;

EID: 0031895236     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/513937     Document Type: Article

References (18)

1. Crislip MA, Edwards JE. Candidiasis. In: Systemic fungal infections diagnosis and treatment part II. Infect Dis Clin North Am 1989;3:103-33.
2. Swartz DA, Harrington P, Wilcox R. Candidal epididymitis treated with ketoconazole [letter]. N Engl J Med 1988;319:1485.
3. Gordon DL, Madde J. Treatment of Candida epididymo-orchitis with oral fluconazole [letter]. Med J Aust 1992;156:744.
4. Docimo SG, Rukstalis DB, Rukstalis MR, Kang J, Cotton D, DeWolf WC. Candida epididymitis: newly recognized opportunistic epididymal infection. Urology 1993;41:280-2.
5. Sheaff M, Ahsan Z, Badenoch D, Baithun S. A rare cause of epididymoorchitis. Br J Urol 1995;75:250-1.
6. Jenks P, Brown J, Warnock D, Barnes N. Candida glabatra epididymoorchitis: an unusual infection rapidly cured with surgical and antifungal treatment. J Infect 1995;31:71-2.
7. Lyne JC, Flood HD. Bilateral fungal epididymo-orchitis with abscess. Urology 1995;46:412-4.
8. Edwards JE Jr. Candida species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:2289-306.
9. Wong-Beringer A, Jacobs RA, Guglielmo J. Treatment of funguria. JAMA 1992;267:2780-5.
10. Hopfer RL. Contemporary techniques for molecular diagnoses of mycoses. Clinical Microbiology Newsletter 1997;19:169-73.
11. Phillips P, Dowd A, Jewesson P, et al. Nonvalue of antigen detection immunoassays for diagnosis of candidaemia. J Clin Microbiol 1990;28:2320-6.
12. Parr NJ, Prasad BRP, Hayhurst V, McMillan A, Leen CS, Fowler JW. Suppurative epididymo-orchitis in young "high risk" patients - a new problem? Br J Urol 1993;72:949-51.
13. Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidaemia in patients without neutropenia. N Engl J Med 1994;331:1325-30.
14. Debruyne D, Ryckelynck JP. Clinical pharmacokinetics of fluconazole. Clin Pharmacokinet 1993;24:10-27.
15. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994;330:263-72.
16. Price MF, LaRocco MT, Gentry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother 1994;38:1422-4.
17. Hitchcock CA, Pye GW, Troke PF, Johnson EM, Warnock DW. Fluconazole resistance in Candida glabatra. Antimicrob Agents Chemother 1993;37:1962-5.
18. Rex JH, Pfaller MA, Galgiani JN, et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro - in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 1997;24:235-47.